The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2

Abstract
The mapping of SARS-CoV-2 human protein-protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host-virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease.
Funding Information
  • NIH (P50AI150476, U19AI135990, U19AI135972, R01AI143292, R01AI120694, P01A1063302, R01AI122747, U54CA209891)
  • NIH (F32CA239336)
  • NIH (F32CA239333)

This publication has 19 references indexed in Scilit: